Pregnancy
Approval for at-home fertility test could ease pressure on the NHS

A Swiss firm has received European approval for its fertility home test kit with real-time results that could relieve the pressure on GPs amid ongoing pressure caused by pandemic.
The Bloom Ovarian Reserve test developed by Bloom Diagnostics measures the AMH (anti-Müllerian hormone), a hormone produced by the granulosa cells in the ovarian follicles, considered a fertility marker.
The single-use self-testing kit for quantitative in-vitro diagnostic examination of the anti-Müllerian hormone is designed for women 18 to 39 years. Pin-prick blood samples are captured in the Bloom test strip, which is then deployed into Bloom’s lab.
Cloud-based algorithms aggregate test results with other information about health status indicators alongside medical history, lifestyle, and individual symptoms. The patient receives fully encrypted feedback through a personalised report on Bloom’s app after 20 minutes.
Low AMH levels can be an indication of Diminished Ovarian Reserve (DOR) and premature ovarian insufficiency (POI). High levels of AMH are common in cases of polycystic ovarian syndrome (PCOS) and can be a risk factor for ovarian hyperstimulation Syndrome (OHHS), potentially a life-threatening complication to hormonal treatment during IVF.
When using Bloom’s system to test AMH levels, the app provides results and a detailed report. Knowing AMH levels support treatments and insights on egg quantity, which is why the use is essential for women who are planning to become pregnant or looking to start a personalised fertility treatment with a specialist.
Angelica Kohlmann, co-founder and chairperson at Bloom Diagnostics said: “This is a game-changing step for home testing and for women. There is nothing of this nature on the market at present and with the addition of the Bloom ovarian reserve test to the Bloom system, women all over the world can now track their egg count with real-time results from the comfort of their homes.
“This is something we welcome during what continues to be a turbulent time for global health care services,” she added.
Find out more here.
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Diagnosis
Home blood pressure checks could lower heart risks for new mothers – study
Pregnancy
More than half of women with gestational diabetes face harmful stigma, research reveals

More than half of women with gestational diabetes report stigma from healthcare staff, family, friends and wider society, new research shows.
A survey of 1,800 UK women found widespread emotional distress at diagnosis of the condition, a form of high blood sugar that develops during pregnancy, with effects lasting beyond birth.
Gestational diabetes affects around one in 20 pregnancies in the UK, and the findings highlight the wider toll on women diagnosed with the condition.
The study was funded by Diabetes UK and led by researchers at King’s College London and University College Cork.
Dr Elizabeth Robertson, director of research and clinical at Diabetes UK, said: “Stigma can have a dangerous and devastating impact on pregnant women diagnosed with gestational diabetes, particularly at a time when emotions and anxieties may already be heightened.
“We know that stigma can lead to shame, isolation and poorer mental health, and may discourage people from attending healthcare appointments, potentially increasing the risk of serious complications.
“This research highlights the urgent need for better support systems, based on understanding and empathy to ensure no one feels blamed or judged during their pregnancy.”
More than two-thirds of women, 68 per cent, reported anxiety at diagnosis, while 58 per cent felt upset and 48 per cent experienced fear.
The psychological impact continued beyond birth, with 61 per cent saying the condition negatively affected their feelings about future pregnancies.
Nearly half of women, 49 per cent, felt judged for having gestational diabetes, while 47 per cent felt judged because of their body size.
More than 80 per cent felt other people did not understand gestational diabetes, and more than a third, 36 per cent, concealed their diagnosis from others.
Gestational diabetes stigma was also common in healthcare settings, with 48 per cent reporting that professionals made assumptions about their diet and exercise, and more than half, 52 per cent, feeling judged based on their blood glucose results.
Many women described a loss of control and a sense of disruption during pregnancy.
Nearly two-thirds, 64 per cent, felt they were denied a normal pregnancy, while 76 per cent reported a lack of control over their pregnancy.
More than a third, 36 per cent, felt abandoned by healthcare services after giving birth, and one in four, 25 per cent, continued to experience depression or anxiety postpartum.
Focus group participants described harmful stereotypes, including assumptions that they were ‘lazy’, had ‘poor eating habits’ or ‘lacked willpower’.
Comments from family and friends included remarks such as “should you be eating that?” and “you must have eaten too much, that’s why you have gestational diabetes.”
The researchers are calling for targeted interventions alongside structured emotional support for women during and after pregnancies affected by gestational diabetes, to improve both mental and physical health outcomes.
Professor Angus Forbes, lead researcher from King’s College London, said: “Stigma and emotional distress are far more common in women diagnosed with gestational diabetes than many realise.
“Everyday interactions, even with those who mean well, can deepen this harm, shaping women’s emotional wellbeing and the choices they feel able to make.
“It’s clear that meaningful action is needed to protect women’s mental and physical health.”
Risk factors for gestational diabetes include living with overweight or obesity, having a family history of type 2 diabetes, and being from a South Asian, Black or African Caribbean or Middle Eastern background.
Entrepreneur7 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News4 weeks agoCopper coil vs Mirena: Which is right for you?














